.Sanofi has created a late entry to the radioligand party, spending 100 million euros ($ 110 million...
.After F2G's very first effort to receive a brand-new lesson of antifungal to market was actually wr...
.Moderna has sworn to cut R&D investing through $1.1 billion through 2027. The decision to retrac...
.Simply four months after Sanofi bet $80 thousand in beforehand money on Pivot Therapeutics' losmapi...
.Cancer cells provider Oncternal Therapies is folding all its own clinical tests as well as giving u...
.Roche is actually storing out chances that its injectable weight problems possibility could ultimat...
.Novo Nordisk has raised the cover on a phase 1 trial of its own oral amylin as well as GLP-1 recept...
.Simply a handful of short weeks after gaining an FDA Fast lane tag for its investigational BTK degr...
.Shortly after a positive records reduce for Eli Lilly's efsitora alfa, the Indianapolis-based compa...
.BridgeBio Pharma is actually slashing its gene therapy finances and also drawing back coming from t...